Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000175604 refers to a non-coding RNA transcript which is antisense to (i.e., overlaps and is transcribed from the opposite DNA strand of) the SNX29 gene. This transcript is annotated in the Ensembl and GeneCards databases, but lacks experimental evidence for protein coding, function, or association with disease. The related SNX29 gene encodes "Sorting nexin 29," a protein involved in phosphatidylinositol binding and has been implicated in processes such as adipose tissue deposition and myogenesis, but the antisense transcript itself has no published function[1][3][5]. Circular RNAs derived from SNX29 ("circSNX29"), primarily in bovine studies, have roles in muscle cell proliferation and differentiation through microRNA-744 sponging and modulation of Wnt5a/CaMKIIδ signaling, but this refers to a different type of RNA product, not the ENSEMBL antisense transcript itself[2]. No molecular targeting, drug interaction, or clinical relevance is reported for this antisense transcript. Summary: This entry describes an uncharacterized, non-coding, antisense RNA overlapping the SNX29 locus. It is not considered a valid therapeutic target, has no known biomolecular classifications, biological function, disease role, or drug interactions, and is essentially a placeholder or reference annotation in current biological databases[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to SNX29.